Clinical trials: Allergic Broncho-Pulmonary Aspergillosis
Pulmonary Cystic Fibrosis, ABPA
Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
In this diagnostic study, the aim is at evaluating the diagnostic accuracy of MRI (Magnetic Resonance Imaging) to detect allergic broncho-pulmonary aspergillosis in patients with cystic fibrosis.
- Trial name
- MRAB (NCT02853175)
- Where
- France
- Volunteers
- 240 people
- Sponsor
- Hôpital Haut Lévêque
Allergic Broncho-Pulmonary Aspergillosis
Protocol TARC-ABPA
The main objective of this study is to determine if a doubling of serum TARC (compared to baseline) is associated with the occurrence of exacerbations of ABPA. The secondary objectives of the study are : 1.
- Trial name
- NCT01710930
- Testing
- Study of predictive factors
- Where
- 2 sites in France
- Volunteers
- 29 people
- Sponsor
- Nantes University Hospital
Allergic Bronchopulmonary Aspergilloses
Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses
The aim of the study is to compare the concordance between chest computerized tomography-scan (CTscan) and Magnetic resonance Imaging (MRI) for the description of the abnormalities seen in Allergic BronchoPulmonary Aspergillosis…
- Trial name
- ABPA-MR (NCT03265366)
- Testing
- MRI, CT scan (standard reference)
- Where
- France
- Volunteers
- 25 people
- Sponsor
- University Hospital, Bordeaux